drugset / Trial / NCT00390312
Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study involves approximately 200 patients designed to evaluate the efficacy and safety of intranasal (IN) morphine 7.5 mg and 15 mg, intravenous morphine (IV) 7.5 mg, immediate release oral (PO) morphine 60 mg or placebo in patients with acute postsurgical pain following third molar extraction.
Timeline
- Start
- 2001-09
- Primary completion
- 2001-11
- Completion
- 2001-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Morphine | Other / unclassified | 7.5 mg | Intranasal |
| Subject | Morphine | Other / unclassified | 15 mg | Intranasal |
| Subject | Morphine | Other / unclassified | 60 mg | Intranasal |
Indications
No indication recorded.